Ai-BrainScience
Funding Series
Series C
Funding Amount
¥29.9m
[data from INITIAL 2024 Dec]
AgTech Healthcare/Medtech

About

Ai-BrainScience Inc. is advancing an innovative eye-tracking technology to assess cognitive function, aiming to revolutionize dementia detection by transforming traditional interview tests into fast, digital solutions—removing key barriers to early diagnosis.

Milestone

This diagnosis method has been approved as a medical device under the name MIREVOⓇ, sold by Otsuka Pharmaceutical Co., Ltd. to support dementia treatment. Ai-BrainScience Inc. aims to expand overseas and further develop its technology.
Visit Site
We're Here to Help
Have questions? Not sure where to start? Send us an email and let’s chat!
Email Us
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.